D&O Ongoing Disclosure – F Hutchings

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Seeka Limited
Date this disclosure made:
14-Mar-22
Date of last disclosure:
26-Oct-21
Director or senior manager giving disclosure
Full name(s):
Fred Allan Hutchings
Name of listed issuer:
Seeka Limited
Name of related body corporate (if applicable):
NA
Position held in listed issuer:
Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary Shares
Nature of the affected relevant interest(s):
1) F A Hutchings has the power to exercise the right to vote
attached to 20% or more of the voting rights of Walker
Nominees Limited, resulting in F Hutchings having a relevant
interest in the Ordinary Shares of Seeka Limited held by
Walker Nominees Limited.
2) Amwell Holdings Limited. F Hutchings is a director of
Amwell Holdings Limited. F Hutchings is the registered
holder of 26.1% of the shares in Amwell Holdings Limited in
his personal capacity and a registered holder of 24.9% of the
shares in Amwell Holdings Limited jointly with others. As
such F Hutchings has the power to control the exercise of
20% or more of the voting rights of Amwell Holdings Limited,
resulting in F Hutchings having a relevant interest in the
Ordinary Shares of Seeka Limited held by Seeka Share
Trustee Limited for and on behalf of Amwell Holdings Limited.
3) Sharesies Nominee Limited holds Ordinary Shares in
Seeka Limited for and on behalf of F A Hutchings
For that relevant interest-
Number held in class before acquisition or disposal:
1) 46,588 Ordinary Shares
2) 2,463 Ordinary Shares
3) 2,501 Ordinary Shares
Number held in class after acquisition or disposal:
1) 47,716 Ordinary Shares
2) 2,523 Ordinary Shares
3) 2,780 Ordinary Shares
Current registered holder(s):
1) NA
2) NA
3) NA
Registered holder(s) once transfers are registered:
1) Walker Nominees Limited
2) Amwell Holdings Limited.
3) Sharesies Nominee Limited on behalf of F A Hutchings
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
NA
Class of underlying financial products:
NA
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any):
NA
A statement as to whether the derivative is cash settled or physically settled:
NA
Maturity date of the derivative (if any):
NA
Expiry date of the derivative(if any):
NA
The price specified in the terms of the derivative (if any):
NA
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the underlying
financial products:
NA
For that derivative,-
Parties to the derivative:
NA

If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:
NA
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 3
Details of transactions requiring disclosure-
Date of transaction:
1) 1 transaction on 18 April 2021, and 2) 2 x transactions on
23 Feb 2022
Nature of transaction:
1 x purchase on market on 18 April 2021 , and 2 x Allotments
pursuant to Seeka Limited's Dividend Reinvestment Plan on
23 February 2022.
Name of any other party or parties to the transaction (if known):
NA
The consideration, expressed in New Zealand dollars, paid or received for the acquisition
or disposal. If the consideration was not in cash and cannot be readily by converted into a
cash value, describe the consideration:
1) 18 April 2021 = $1,395 (279 shares purchased on market
at $5.00 each); 2)
23 February 2022 for $5,636.9544 (1,128 Ordinary Shares at
$4.9973 each) and $299.8380 for (60 Ordinary Shares at
$4.9973 each)
Number of financial products to which the transaction related:
1,188 ordinary shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
NA
Date of the prior written clearance (if any):
NA
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:NA
Nature of relevant interest:
NA
For that relevant interest,-
Number held in class:
NA
Current registered holder(s):
NA
For a derivative relevant interest,-
Type of derivative:NA
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any):
NA
A statement as to whether the derivative is cash settled or physically settled:NA
Maturity date of the derivative (if any):NA
Expiry date of the derivative (if any):NA
The price's specified terms (if any):NA
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the underlying
financial products:
NA
For that derivative relevant interest,- NA
Parties to the derivative:
NA
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:
NA
Certification
I certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all persons
for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
14-Mar-22
Name and title of authorised person:
F Hutchings